Brad Schaeffer MedComp

Brad Schaeffer of Medcomp Sciences Explains Who Needs a Toxicology Screen and What Can the Results Explain?

Brad Schaeffer Medcomp Sciences

Toxicology is a field of science that helps people understand the harmful affects of toxic substances, chemicals, or situations that can have on animals, people, and the environment. It is the practice of diagnosing and treating people, animals or the environment that have been exposed to these harmful toxins. Brad Shaeffer of Medcomp Sciences has been the President of the company since 2012. Medcomp Sciences provides customers with urine toxicology testing, genetic testing, and COVID-19 testing services. Brad Schaeffer with Medcomp Sciences makes sure that patients know how their bodies will react to over 150 different medications using a single DNA test. So, the question comes down to who needs a toxicology screening and what can the results explain?

First off, most of these tests are done quickly using a urine of blood sample. In some cases, a saliva or hair sample might be used. There are four main types of toxicology screening, athletics testing, medical testing, forensic testing, and employment drug testing.  If a person has taken illegal drugs or has tried to harm themselves in some way, a doctor will perform a toxicology screen. A doctor will see the following symptoms as a strong sign that they could have intoxication or overdosed on drugs. These symptoms are vomiting, seizures, confusion, chest pain, panic attacks, deliriousness, unconsciousness, and difficulty breathing. Another example of someone who might need the toxicology screening would be a potential employee for a company, Employers will screen individuals who have applied for a job to see if they have any traces of drugs in their system. This is the same for athletes who use performance enhancing drugs, such as steroids. People who work in law enforcement might ask for a toxicology report while investigating a car accident or a sexual assault case.

Here is a list of drugs that a toxicology screening can detect:

  • Cocaine
  • Methadone
  • Barbiturates
  • Benzodiazepines
  • Phencyclidine (PCP)
  • Tetrahydrocannabinol (THC)
  • Amphetamines, such as Adderall
  • Alcohol, including Ethanol and Methanol.
  • Opiates, including Codeine, Oxycodone, and Heroin

What can these results explain? These reports provide a limited amount of information as to how often or how long the person has taken the drug. These results come back as either a positive or a negative result. Negative results mean that no trace of drugs was found. Positive means that a drug or many drugs are present in that person’s body. By having a toxicology screening done, it can help doctors, employers, and law enforcement make decisions to move forward with either further testing or confirm results.

Brad Schaeffer MedComp

Brad Schaefer of Medcomp Sciences Discusses the Different Types of Genetic Testing

Within the last fifty years, genetic testing has become an indispensable tool for numerous medical professionals diagnosticians around the globe. For readers who are unaware, genetic testing refers to the analysis of DNA and is most often used to identify changes in the gene sequence. Genetic testing can be used to reveal mutations in genes that can cause illness and disease, helping doctors deliver more accurate diagnoses. For over nine years, Medcomp Sciences has worked to provide medical firm services straight to customer homes by offering prescription product access, concierge care, and at-home diagnostic testing. Brad Schaeffer, CEO of Medcomp Sciences, hopes that by providing consumers medical transparency and access to various healthcare services, he can help promote personal health. Today, Brad Schaefer of Medcomp Sciences hopes to spread awareness regarding a variety of personal health topics and, today, will discuss the different types of genetic testing currently available to Medcomp Sciences customers.

Single- Gene Testing

Single gene tests analyze potential changes and mutations in one individual gene. Single gene testing is often recommended when a doctor believes a patient has symptoms of a specific condition or syndrome. The majority of single-gene tests are performed using full sequencing analysis with customized next-generation sequencing library and high resolution (exon-specific) deletion/duplication analysis. Single gene tests are often used to diagnose several illnesses, including Duchene muscular dystrophy, cystic fibrosis, and Angleman syndrome.

Panel Testing

Panel genetic tests or “multi-gene genetic tests”, look for changes in a variety of genes. These genetic tests are often grouped in categories based on each patient’s different medical concerns, including muscle tone, epilepsy, or family history of cancer. Panel genetic testing looks for inherited mutations in a variety of different genes that are often associated with breast cancer, hereditary diffuse gastric cancer, uterine cancer, Fanconi’s anemia, and a variety of other illnesses.

Large-scale Genetic

There are two types of large-scale genetic tests, exome sequencing external icon and genome sequencing external icon. Exome sequencing external icon looks at all genes present in DNA or the genes related to a medical condition (clinical exome). Genome sequencing external icon is the most extensive genetic test available and looks at all of a patient’s DNA. Large-scale genetic tests are frequently offered to patients with complex medical histories and family histories.

Brad Schaeffer MedComp

Brad Schaeffer of Medcomp Sciences says Testing still Vital ahead of Vaccine Availability

Brad Schaeffer of Medcomp Sciences

Public interest in medicine, testing, side effects and availability has never been so high. We can thank the coronavirus pandemic for that. If anything, this health crisis has helped strengthen the bond between patients and clinical scientists doing difficult work in laboratories across the globe. Brad Schaeffer, Medcomp Sciences’ president and CEO, is no stranger to that line of work. He’s been at the helm of this medical/clinical diagnosis laboratory since mid-2012 and has helped provide clients with testing products that explain the condition of a patient. His company is currently providing two forms of tests, which will discuss below, to detect the presence of COVID-19 antibodies. With the roll-out of vaccines now under way, Brad Schaeffer of Medcomp Sciences wants readers to understand the intricate work that lies ahead.

Getting shots of the COVID-19 vaccine out to the general public entails a number of logistical hurdles. Chief among them is temperature, which is something clinical technicians will be familiar with. According to the Centers for Disease Control, the Moderna vaccine will arrive to distributors still frozen and must be stored in a freezer that maintains a temperature between -13 and 5 degrees Fahrenheit. “If storing the vaccine in a freezer with routinely recommended vaccines, carefully adjust the freezer temperature to the correct temperature range for this vaccine,” the CDC advises, adding that dry ice should not be used for storage and keeping the vials out of direct sunlight is also important.

These protocols from the CDC barely scratch the surface of efforts that have gone into creating a virus vaccine in a record-shattering amount of time. Brad Schaeffer of Medcomp Sciences is confident that the tests provided by his clinical laboratory gave vaccine developers just a little bit more breathing room to roll out their product. The two tests offered are Active Infection Genetic and Immune Response Antibody. The former test would tell doctors that the patient is currently infected with the COVID-19 virus while the latter would show a previous infection due to the presence of antibodies. Knowing that someone is currently infected and having them quarantine away from the general population has been instrumental in slowing the spread of the disease and keeping infection rates from spiking out of control.

Brad Schaeffer of Medcomp Sciences further points to boots-on-the-ground efforts by his company, which included free testing at Louisiana’s Zachary Youth Park in May 2020. Mr. Schaeffer says these offerings are all part of the puzzle to keep people safe and healthy until fellow clinical scientists can work on widespread vaccinations.